vs
Axos Financial, Inc.（AX）与Pediatrix Medical Group, Inc.（MD）财务数据对比。点击上方公司名可切换其他公司
Pediatrix Medical Group, Inc.的季度营收约是Axos Financial, Inc.的1.3倍（$493.8M vs $392.2M），Axos Financial, Inc.净利率更高（31.8% vs 6.8%，领先25.0%），过去两年Axos Financial, Inc.的营收复合增速更高（16.1% vs -0.1%）
Axos Financial是总部位于美国内华达州拉斯维加斯的银行控股公司，旗下拥有直销银行Axos Bank，同时提供注册投资顾问服务及电子交易平台，深耕数字化金融赛道，可为用户提供多元便捷的金融服务解决方案。
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
AX vs MD — 直观对比
营收规模更大
MD
是对方的1.3倍
$392.2M
净利率更高
AX
高出25.0%
6.8%
两年增速更快
AX
近两年复合增速
-0.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $392.2M | $493.8M |
| 净利润 | $124.7M | $33.7M |
| 毛利率 | — | — |
| 营业利润率 | — | 9.9% |
| 净利率 | 31.8% | 6.8% |
| 营收同比 | — | -1.7% |
| 净利润同比 | 18.5% | 10.5% |
| 每股收益（稀释后） | $2.15 | $0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXMD
| Q1 26 | $392.2M | — | ||
| Q4 25 | $385.1M | $493.8M | ||
| Q3 25 | $323.4M | $492.9M | ||
| Q2 25 | $321.4M | $468.8M | ||
| Q1 25 | $308.8M | $458.4M | ||
| Q4 24 | $307.9M | $502.4M | ||
| Q3 24 | $320.7M | $511.2M | ||
| Q2 24 | $290.9M | $504.3M |
净利润AXMD
| Q1 26 | $124.7M | — | ||
| Q4 25 | $128.4M | $33.7M | ||
| Q3 25 | $112.4M | $71.7M | ||
| Q2 25 | $110.7M | $39.3M | ||
| Q1 25 | $105.2M | $20.7M | ||
| Q4 24 | $104.7M | $30.5M | ||
| Q3 24 | $112.3M | $19.4M | ||
| Q2 24 | $104.9M | $-153.0M |
营业利润率AXMD
| Q1 26 | — | — | ||
| Q4 25 | 45.6% | 9.9% | ||
| Q3 25 | 46.3% | 13.8% | ||
| Q2 25 | 48.5% | 12.8% | ||
| Q1 25 | 47.9% | 7.0% | ||
| Q4 24 | 48.8% | 7.8% | ||
| Q3 24 | 49.6% | 6.6% | ||
| Q2 24 | 49.6% | -31.3% |
净利率AXMD
| Q1 26 | 31.8% | — | ||
| Q4 25 | 33.3% | 6.8% | ||
| Q3 25 | 34.7% | 14.5% | ||
| Q2 25 | 34.4% | 8.4% | ||
| Q1 25 | 34.1% | 4.5% | ||
| Q4 24 | 34.0% | 6.1% | ||
| Q3 24 | 35.0% | 3.8% | ||
| Q2 24 | 36.0% | -30.3% |
每股收益（稀释后）AXMD
| Q1 26 | $2.15 | — | ||
| Q4 25 | $2.22 | $0.40 | ||
| Q3 25 | $1.94 | $0.84 | ||
| Q2 25 | $1.89 | $0.46 | ||
| Q1 25 | $1.81 | $0.24 | ||
| Q4 24 | $1.80 | $0.37 | ||
| Q3 24 | $1.93 | $0.23 | ||
| Q2 24 | $1.75 | $-1.84 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $375.2M |
| 总债务越低越好 | — | $570.5M |
| 股东权益账面价值 | $3.1B | $865.9M |
| 总资产 | $29.2B | $2.2B |
| 负债/权益比越低杠杆越低 | — | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资AXMD
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | $375.2M | ||
| Q3 25 | $2.6B | $340.1M | ||
| Q2 25 | $1.9B | $224.7M | ||
| Q1 25 | $2.0B | $99.0M | ||
| Q4 24 | $2.4B | $229.9M | ||
| Q3 24 | $2.6B | $103.8M | ||
| Q2 24 | $2.0B | $19.4M |
总债务AXMD
| Q1 26 | — | — | ||
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | $312.7M | $583.9M | ||
| Q1 25 | $377.4M | $590.5M | ||
| Q4 24 | $358.7M | $597.1M | ||
| Q3 24 | $313.5M | — | ||
| Q2 24 | $325.7M | — |
股东权益AXMD
| Q1 26 | $3.1B | — | ||
| Q4 25 | $2.9B | $865.9M | ||
| Q3 25 | $2.8B | $890.7M | ||
| Q2 25 | $2.7B | $833.8M | ||
| Q1 25 | $2.6B | $789.2M | ||
| Q4 24 | $2.5B | $764.9M | ||
| Q3 24 | $2.4B | $732.5M | ||
| Q2 24 | $2.3B | $706.5M |
总资产AXMD
| Q1 26 | $29.2B | — | ||
| Q4 25 | $28.2B | $2.2B | ||
| Q3 25 | $27.4B | $2.2B | ||
| Q2 25 | $24.8B | $2.1B | ||
| Q1 25 | $24.0B | $2.0B | ||
| Q4 24 | $23.7B | $2.2B | ||
| Q3 24 | $23.6B | $2.1B | ||
| Q2 24 | $22.9B | $2.0B |
负债/权益比AXMD
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | 0.12× | 0.70× | ||
| Q1 25 | 0.14× | 0.75× | ||
| Q4 24 | 0.14× | 0.78× | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.14× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $114.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.39× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXMD
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $114.1M | ||
| Q3 25 | $118.4M | $137.3M | ||
| Q2 25 | $490.3M | $137.2M | ||
| Q1 25 | $73.7M | $-117.5M | ||
| Q4 24 | $162.5M | $133.0M | ||
| Q3 24 | $70.8M | $91.8M | ||
| Q2 24 | $305.5M | $107.0M |
自由现金流AXMD
| Q1 26 | — | — | ||
| Q4 25 | $85.4M | — | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | $436.1M | — | ||
| Q1 25 | $65.1M | — | ||
| Q4 24 | $156.4M | — | ||
| Q3 24 | $53.0M | — | ||
| Q2 24 | $269.5M | — |
自由现金流率AXMD
| Q1 26 | — | — | ||
| Q4 25 | 22.2% | — | ||
| Q3 25 | 33.8% | — | ||
| Q2 25 | 135.7% | — | ||
| Q1 25 | 21.1% | — | ||
| Q4 24 | 50.8% | — | ||
| Q3 24 | 16.5% | — | ||
| Q2 24 | 92.6% | — |
资本支出强度AXMD
| Q1 26 | — | — | ||
| Q4 25 | 4.9% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 16.9% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 2.0% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 12.4% | — |
现金转化率AXMD
| Q1 26 | — | — | ||
| Q4 25 | 0.81× | 3.39× | ||
| Q3 25 | 1.05× | 1.91× | ||
| Q2 25 | 4.43× | 3.49× | ||
| Q1 25 | 0.70× | -5.66× | ||
| Q4 24 | 1.55× | 4.36× | ||
| Q3 24 | 0.63× | 4.72× | ||
| Q2 24 | 2.91× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AX
| Net Interest Income | $306.3M | 78% |
| Noninterest Income | $86.0M | 22% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
